Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 239
The Anthrax Vaccine: Is it Safe? Does it Work? Appendix E Vaccine Adverse Event Reporting System (VAERS) Form
OCR for page 240
The Anthrax Vaccine: Is it Safe? Does it Work? This page in the original is blank.
OCR for page 241
The Anthrax Vaccine: Is it Safe? Does it Work?
OCR for page 242
The Anthrax Vaccine: Is it Safe? Does it Work? DIRECTIONS FOR COMPLETING FORM (Additional pages may be attached if more space is needed) GENERAL Use a separate form for each patient. Complete the form to the best of your abilities. Items 3, 4, 7, 8, 10, 11, and 13 are considered essential and should be completed whenever possible. Parents/Guardians may need to consult the facility where the vaccine was administered for some of the information (such as manufacturer, lot number or laboratory data.) Refer to the Reportable Events Table (RET) for events mandated for reporting by law. Reporting for other serious events felt to be related but not on the RET is encouraged. Health care providers other than the vaccine administrator (VA) treating a patient for a suspected adverse event should notify the VA and provide the information about the adverse event to allow the VA to complete the form to meet the VA's legal responsibility. These data will be used to increase understanding of adverse events following vaccination and will become part of CDC Privacy Act System 09-20-0136, "Epidemiologic Studies and Surveillance of Disease Problems". Information identifying the person who received the vaccine orthat person's legal representativewill not be made available tothe public, but may be available to the vaccinee or legal representative. Postage will be paid by addressee. Forms may be photocopied (must be front & back on same sheet). SPECIFIC INSTRUCTIONS Form Completed By: To be used by parents/guardians, vaccine manufacturers/distributors, vaccine administrators, and/or the person completing the form on behalf of the patient or the health professional who administered the vaccine. Item 7: Describe the suspected adverse event. Such things as temperature, local and general signs and symptoms, time course, duration of symptoms diagnosis, treatment and recovery should be noted. Item 9: Check "YES" if the patient's health condition is the same as it was prior to the vaccine, "NO" if the patient has not returned to the pre-vaccination state of health, or "UNKNOWN" if the patient's condition is not known. Item 10: Give dates and times as specifically as you can remember. If you do not know the exact time, please Item 11: indicate "AM" or "PM" when possible if this information is known. If more than one adverse event, give the onset date and time for the most serious event. Item 12: Include "negative" or "normal" results of any relevant tests performed as well as abnormal findings. Item 13: List ONLY those vaccines given on the day listed in Item 10. Item 14: List any other vaccines that the patient received within 4 weeks prior to the date listed in Item 10. Item 16: This section refers to how the person who gave the vaccine purchased it, not to the patient's insurance. Item 17: List any prescription or non-prescription medications the patient was taking when the vaccine(s) was given. Item 18: List any short term illnesses the patient had on the date the vaccine(s) was given (i.e., cold, flu, ear infection). Item 19: List any pre-existing physician-diagnosed allergies, birth defects, medical conditions (including developmental and/or neurologic disorders) for the patient. Item 21: List any suspected adverse events the patient, or the patient's brothers or sisters, may have had to previous vaccinations. If more than one brother or sister, or if the patient has reacted to more than one priorvaccine, use additional pages to explain completely. For the onset age of a patient, provide the age in months if less than two years old. Item 26: This space is for manufacturers' use only.
Representative terms from entire chapter: